STC
UTHR icon

SEI Trust Company’s United Therapeutics UTHR Stock Holding History

SEI Trust Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7.83M Buy
60,905
+23,713
+64% +$2.44M 0.08% 305
2014
Q2 		$3.29M Sell
37,192
-20,301
-35% -$1.95M 0.03% 522
2014
Q1 		$5.41M Buy
57,493
+12,060
+27% +$1.23M 0.05% 381
2013
Q4 		$5.14M Sell
45,433
-44,637
-50% -$4.03M 0.05% 407
2013
Q3 		$7.1M Buy
90,070
+48,640
+117% +$3.56M 0.08% 291
2013
Q2 		$2.73M Buy
+41,430
New +$2.67M 0.03% 483

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SEI Trust Company's UTHR Position: Q3 2014 in Review

SEI Trust Company increased its United Therapeutics (UTHR) stake by 64% in Q3 2014, buying an estimated $2.44M and bringing the position to 60,905 shares worth $7.83M. The position accounts for 0.08% of the portfolio, ranked #305.

SEI Trust Company first reported a position in UTHR in Q2 2013 and has held it in 6 quarters since. 319 funds tracked by Wall St. Rank hold UTHR as of Q3 2014.

  • SEI Trust Company held 60,905 shares of United Therapeutics worth $7.83M as of Q3 2014.
  • SEI Trust Company bought 23,713 United Therapeutics shares in Q3 2014, an estimated $2.44M.
  • United Therapeutics made up 0.08% of SEI Trust Company's portfolio in Q3 2014, its #305 holding.
  • SEI Trust Company first reported a position in United Therapeutics in Q2 2013 and has held it in 6 quarters since.
  • 319 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.